Pharmaron Beijing Co Ltd (PHBBF)
1.93
0.00 (0.00%)
USD |
OTCM |
Jun 28, 16:00
Pharmaron Beijing Revenue (Quarterly): 397.98M for March 31, 2023
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2023 | 397.98M |
| December 31, 2022 | 402.53M |
| September 30, 2022 | 404.10M |
| June 30, 2022 | 382.99M |
| March 31, 2022 | 330.83M |
| December 31, 2021 | 334.75M |
| September 30, 2021 | 311.30M |
| June 30, 2021 | 277.99M |
| March 31, 2021 | 229.55M |
| December 31, 2020 | 233.41M |
| September 30, 2020 | 201.16M |
| Date | Value |
|---|---|
| June 30, 2020 | 174.02M |
| March 31, 2020 | 137.39M |
| December 31, 2019 | 160.51M |
| September 30, 2019 | 141.10M |
| June 30, 2019 | 128.00M |
| March 31, 2019 | 113.07M |
| December 31, 2018 | 126.19M |
| September 30, 2018 | 112.40M |
| June 30, 2018 | 108.08M |
| March 31, 2018 | 91.50M |
| December 31, 2017 | 102.46M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
128.00M
Minimum
Jun 2019
404.10M
Maximum
Sep 2022
265.48M
Average
255.70M
Median
Revenue (Quarterly) Benchmarks
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | 50.88M |
| Total Expenses (Quarterly) | 335.19M |
| EPS Diluted (Quarterly) | 0.0431 |